Search clinical trials for: Antirheumatic Agents

Total 188203 results

Catholic University of the Sacred Heart
Merck Sharp & Dohme LLC

Completed

Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease

Crohn's Disease | Ulcerative Colitis

Italy
Janssen Inc.

Completed

Remicade Infusion Management Program (RemiTRAC)

Arthritis, Rheumatoid | Crohn Disease

Canada
University of Western Ontario, Canada
Schering-Plough

Completed

Study to Determine Relationship Between Serum Infliximab and Efficacy in Luminal Crohn's Disease Patients (X-Sectional)

Crohn's Disease

Canada
Cedars-Sinai Medical Center

Unknown

Durability and Tolerability of Infliximab in Pediatric Inflammatory Bowel Disease Patients: A 10 Year Single Center Experience

Pediatric Inflammatory Bowel Disease
Second Affiliated Hospital, School of Medicine,...

Completed

The Impact of Medication Belief on Adherence to Infliximab in Patients With Crohn's Disease

Inflammatory Bowel Diseases

China
Mayo Clinic

Completed

Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis

Colitis, Ulcerative | Inflammatory Bowel Disease | IBD

United States
Corporacion Parc Tauli

Completed

Metabolomic Markers of Fatigue in Inflammatory Bowel Disease

Fatigue | Crohn Disease | Ulcerative Colitis | Inflammatory Bowel Disease
University of Western Ontario, Canada

Withdrawn

Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody Levels (OPTIMIZE)

Crohn's Disease | Ulcerative Colitis
KU Leuven
Fund for Scientific Research, Flanders, Belgium

Completed

Mucosal Gene Expression Defects in IBD

Inflammatory Bowel Diseases

Belgium
Rheumazentrum Ruhrgebiet
Centocor Ortho Biotech Services, L.L.C.

Unknown

European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study (EASIC registry)

Ankylosing Spondylitis

Belgium, Germany, Finland, France, Netherlands, United Kingdom
University Hospital, Rouen

Not yet recruiting

Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration (FEFACRIGOU)

Gout
Shanghai Jiao Tong University School of Medicine
Shanghai Clinical Research Center

Not yet recruiting

Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis

GVHD

China
Suzhou BlueHorse Therapeutics Co., Ltd.

Recruiting

A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors

Solid Tumor

China
Bio-Thera Solutions

Recruiting

Clinical Study of Stage IV Psoriasis in Children With Geleli

Plaque Psoriasis

China
Shanghai Unicar-Therapy Bio-medicine Technology...

Recruiting

Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Relapsed or Refractory Non-Hodgkin's Lymphoma

China
Global Healthy Living Foundation
University of Alabama at Birmingham; Illumination Health

Recruiting

The ArthritisPower Wearable Study (WEAR)

Rheumatoid Arthritis

United States
Fresenius Kabi

Not yet recruiting

bIosimilar of aDalimumab, an European evAluation (IDEA)

Rheumatoid Arthritis | Crohn Disease | Ulcerative Colitis | Psoriatic Arthritis | Ankylosing Spondylitis
Nkarta Inc.

Recruiting

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

Lymphoma, Non-Hodgkin | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | B-cell Acute Lymphoblastic Leukemia | Small Lymphocytic Lymphoma | Large B-cell Lymphoma | Indolent Lymphoma | Aggressive Lymphoma | Large-cell Lymphoma

United States, Australia
First Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

PD-1 Inhibitor Concurrent With Chemotherapy as Neoadjuvant Therapy for TNBC (NeoPD1TNBC)

Triple Negative Breast Cancer

China
ITB-Med LLC

Recruiting

A Study of TCD601 in the Induction of Tolerance in de Novo Renal Transplantation (PERSPECTIVE)

Kidney Transplantation

United States, Korea, Republic of
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Recruiting

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer Stage IV | Ovarian Cancer Stage III | Fallopian Tube Cancer Stage IV | Fallopian Tube Cancer Stage III

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old) (GRAALL-2014/T)

T-cell Adult Acute Lymphoblastic Leukemia

France
National Eye Institute (NEI)

Recruiting

Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene

Retinal Disease | Genotype

United States
AbbVie

Completed

Chronic Plaque Psoriasis (Ps) Registry

Chronic Plaque Psoriasis

United States, Austria, Canada, Czechia, Denmark, France, Germany, Greece, Ireland, Netherlands, Puerto Rico, Spain, Sweden, United Kingdom
Brigham and Women's Hospital
Harvard Medical School (HMS and HSDM)

Completed

People-Powered Medicine (PPM): Rheumatoid Arthritis Non-responders to Biologic Therapies (RANT) (PPM:RANT)

Rheumatoid Arthritis

United States
University Hospital, Toulouse

Withdrawn

Hydroxychloroquine for the Treatment of SARS-CoV2 (COVID 19) : Pharmacokinetic Study (CHLORO-VID)

COVID-19 Pneumonia

France
University of Cologne
Novartis

Terminated

TisaGenlecleucel in Elderly Patients With First-Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma (TIGER-CTL019)

Non Hodgkin Lymphoma

Germany
University of Aarhus

Active, not recruiting

Phase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN Study

Malignant Lymphoma

Netherlands, Norway, Denmark, Finland, Sweden
AbbVie

Completed

HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis

Uveitis

Japan
University of California, San Diego
Abbott; The Organization of Teratology Information Specialists

Completed

OTIS Autoimmune Diseases in Pregnancy Project

Rheumatoid Arthritis | Crohn's Disease

United States
Hospital Nacional Carlos Alberto Seguin Escobedo...

Completed

Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV) (TEDHICOV)

Covid19 | SARS-CoV Infection | Tenofovir

Peru
AbbVie

Completed

Observational Study Evaluating the Effectiveness of Drug Concentration to Predict the Recapture of Response in Crohn's Disease Patients With Loss of Response ( PRADA ) (PRADA)

Crohn's Disease

Canada
AbbVie (prior sponsor, Abbott)
Cato Research; JSS Medical Research Inc.

Completed

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis (Complete-AS)

Ankylosing Spondylitis

Canada
AbbVie

Completed

A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation (Adherence)

Spondylarthritis | Psoriatic Arthritis | Ankylosing Spondylitis (AS)

Russian Federation
AbbVie (prior sponsor, Abbott)

Completed

Documentation of Humira in Psoriasis Patients in Routine Clinical Practice (LOTOS)

Moderate to Severe Plaque Psoriasis

Germany
AbbVie

Completed

Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea (ped PsO rPMS)

Psoriasis

Korea, Republic of
Institute of Hematology & Blood Diseases Hospital
Shanghai Cell Therapy Engineering Technology Research Center Group Co., Ltd.

Unknown

Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Transformed Lymphoma

China
AbbVie

Completed

Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting (HARMONY)

Hidradenitis Suppurativa

Austria, Belgium, Czechia, Germany, Greece, Hungary, Ireland, Israel, Lebanon, Slovenia, Switzerland, Turkey, United Kingdom
AbbVie

Completed

A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice (EUREKA)

Ulcerative Colitis

Korea, Republic of
Zhao Weili
Shanghai Mingju Biotechnology Co., Ltd.

Unknown

Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Non Hodgkin Lymphoma

China
AbbVie (prior sponsor, Abbott)
Veeda Clinical Research

Completed

A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct ) (ProAct)

Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis
AbbVie

Completed

Special Investigation in Patients With Ulcerative Colitis

Ulcerative Colitis
AbbVie

Completed

Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)

Behcet's Disease
AbbVie

Completed

Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab (ROCKA)

Rheumatoid Arthritis
AbbVie (prior sponsor, Abbott)

Completed

Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis (AGIL)

Rheumatoid Arthritis
AbbVie

Completed

Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium (SPACTIVE)

Psoriatic Arthritis | Ankylosing Spondylitis
Shenzhen Second People's Hospital

Unknown

Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma

Multiple Myeloma in Relapse

China
AbbVie (prior sponsor, Abbott)

Completed

Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))

Rheumatoid Arthritis

Japan
Novartis Pharmaceuticals

Terminated

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients (VAY736Y)

Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Spain, United States
AbbVie (prior sponsor, Abbott)

Completed

Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)

Rheumatoid Arthritis

Search clinical trials for: Antirheumatic Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations